Trial intelligence / Profile preview

Pilot RCT of PCC vs FFP in adult heart surgery

2018-003041-41Phase 2Completed

Sponsor
Queen Mary University of London
Start
Sep 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial of coagulation factor X human in intraoperative bleeding and Not applicable (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Recruitment rate and intervention delivery and Trial process feasibility. Started Sep 2018; status: completed.

02

Drugs

coagulation factor X human
03

Conditions

intraoperative bleedingNot applicable

Beyond the preview

Go deeper on 2018-003041-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003041-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call